Here we used a modified gene-specific target enrichment using CRISPR/Cas9 followed by LRS19,20 to comprehensively analyze the gene structure of ASPA in five patients in our cohort presenting with a clinical and biochemical diagnosis of CD who were lacking a second pathogenic in trans variant. This evidence concerns the gene ASPA and Cowden disease.